UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

The Prostate, 1999-01, Vol.38 (1), p.73-78

1999

Volltextzugriff (PDF)

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

The Prostate, 1999-04, Vol.39 (1), p.54-59

1999

Volltextzugriff (PDF)

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

The Prostate, 1998-06, Vol.36 (1), p.39-44

1998

Volltextzugriff (PDF)

Follow-up evaluation of a phase II prostate cancer vaccine trial

The Prostate, 1999-07, Vol.40 (2), p.125-129

1999

Volltextzugriff (PDF)

Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases

The Journal of biological chemistry, 1990-11, Vol.265 (32), p.19401-19404

1990

Volltextzugriff (PDF)

CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells

Journal of surgical oncology, 1998-10, Vol.69 (2), p.99-104

1998

Volltextzugriff (PDF)

Reduced connexin43 expression in high-grade human brain glioma cells

Journal of surgical oncology, 1999-01, Vol.70 (1), p.21-24

1999

Volltextzugriff (PDF)

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

The Prostate, 1997-09, Vol.32 (4), p.272-278

1997

Volltextzugriff (PDF)

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

The Prostate, 1999-06, Vol.39 (4), p.291-297

1999

Volltextzugriff (PDF)

Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation

Carcinogenesis (New York), 2001-08, Vol.22 (8), p.1163-1172

2001

Volltextzugriff (PDF)

Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43)

Cancer research (Chicago, Ill.), 1998-11, Vol.58 (22), p.5089-5096

1998

Volltextzugriff (PDF)

Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases

Toxicon (Oxford), 1994-03, Vol.32 (3), p.339-350

1994

Volltextzugriff (PDF)

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

The Prostate, 1998-05, Vol.35 (2), p.144-151

1998

Volltextzugriff (PDF)

Dendritic cell-based immunotherapy for prostate cancer

CA: a cancer journal for clinicians, 1999-03, Vol.49 (2), p.117-128

1999

Volltextzugriff (PDF)

Tumor promotion by hydrogen peroxide in rat liver epithelial cells

Carcinogenesis (New York), 1999-03, Vol.20 (3), p.485-492

1999

Volltextzugriff (PDF)

ISOLATION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR THE EXTRACELLULAR DOMAIN OF PROSTATE SPECIFIC MEMBRANE ANTIGEN

The Journal of urology, 1998-12, Vol.160 (6), p.2396-2401

1998

Volltextzugriff (PDF)

Molecular characterization of CXCR-4: A potential brain tumor-associated gene

Journal of surgical oncology, 1998-12, Vol.69 (4), p.239-248

1998

Volltextzugriff (PDF)

Report from the International Union against Cancer (UICC) Tumor Biology Committee: UICC Workshop on the use of dendritic cells in Cancer Clinical Trials

Cancer, 1999-12, Vol.86 (12), p.2674-2683

1999

Volltextzugriff (PDF)

Identification, purification, and characterization of a novel serine/threonine protein phosphatase from bovine brain

The Journal of biological chemistry, 1991-04, Vol.266 (10), p.6614-6619

1991

Volltextzugriff (PDF)

Suppression of human fibrosarcoma cell growth by transcription factor, Egr‐1, involves down‐regulation of Bcl‐2

International journal of cancer, 1998-09, Vol.77 (6), p.880-886

1998

Volltextzugriff (PDF)

Evaluation and comparison of two new prostate carcinoma markers: Free‐prostate specific antigen and prostate specific membrane antigen

Cancer, 1996-08, Vol.78 (4), p.809-818

1996

Volltextzugriff (PDF)

Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases

Molecular pharmacology, 1991-10, Vol.40 (4), p.577-583

1991

Volltextzugriff (PDF)

Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells

Anticancer research, 1999-11, Vol.19 (6B), p.4947

1999

Volltextzugriff (PDF)

Cell adhesion molecule Nr‐CAM is over‐expressed in human brain tumors

International journal of cancer, 1998-05, Vol.76 (4), p.451-458

1998

Volltextzugriff (PDF)

Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients

The Prostate, 1997-12, Vol.33 (4), p.281-285

1997

Volltextzugriff (PDF)

1 – 25 von 1.016

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(851)
Mit Volltextzugriff
(820)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(500)
Life Sciences & Biomedicine
(292)
Humans
(179)
Physical Sciences
(175)
Biological And Medical Sciences
(142)
Animals
(99)
Medical Sciences
(84)
Male
(76)
Astronomy & Astrophysics
(73)
Mars
(63)
Social Sciences
(63)
Female
(62)
Extraterrestrial Geology
(61)
Fundamental And Applied Biological Sciences. Psychology
(59)
Geochemistry & Geophysics
(58)
Rats
(56)
Oncology
(47)
Planets
(45)
Exact Sciences And Technology
(44)
Technology
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

Follow-up evaluation of a phase II prostate cancer vaccine trial

Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases

CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells

Reduced connexin43 expression in high-grade human brain glioma cells

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial

Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation

Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43)

Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

Dendritic cell-based immunotherapy for prostate cancer

Tumor promotion by hydrogen peroxide in rat liver epithelial cells

ISOLATION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR THE EXTRACELLULAR DOMAIN OF PROSTATE SPECIFIC MEMBRANE ANTIGEN

Molecular characterization of CXCR-4: A potential brain tumor-associated gene

Report from the International Union against Cancer (UICC) Tumor Biology Committee: UICC Workshop on the use of dendritic cells in Cancer Clinical Trials

Identification, purification, and characterization of a novel serine/threonine protein phosphatase from bovine brain

Suppression of human fibrosarcoma cell growth by transcription factor, Egr‐1, involves down‐regulation of Bcl‐2

Evaluation and comparison of two new prostate carcinoma markers: Free‐prostate specific antigen and prostate specific membrane antigen

Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases

Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells

Cell adhesion molecule Nr‐CAM is over‐expressed in human brain tumors

Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients

Suchergebnisse filtern